1. Kim BH, Park JW. Epidemiology of liver cancer in South Korea. Clin Mol Hepatol. 2018; 24:1–9.
2. Kweon SS. Epidemiology of liver cancer in Korea. J Korean Med Assoc. 2019; 62:416–423.
3. Yoo KY. Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 2008; 38:327–333.
4. Suh M, Song S, Cho HN, Park B, Jun JK, Choi E, et al. Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012. Cancer Res Treat. 2017; 49:798–806.
5. Kim Y, Jun JK, Choi KS, Lee HY, Park EC. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev. 2011; 12:725–730.
6. Korean Liver Cancer Association; National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver. 2019; 13:227–299.
7. Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, Lee JS. Survival of Korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat. 2013; 45:162–171.
8. Kwon JW, Tchoe HJ, Lee J, Suh JK, Lee JH, Shin S. The impact of national surveillance for liver cancer: Results from Real-World Setting in Korea. Gut Liver. 2020; 14:108–116.
9. Jung M. National Cancer Screening Programs and evidence-based healthcare policy in South Korea. Health policy. 2015; 119:26–32.
10. Shim JJ, Park HJ, Kim JW, Hwang EJ, Lee CK, Jang JY, et al. The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011. Korean J Med. 2013; 84:672–680.
11. Choi IS, Oh CH, Park SY, Ahn SE, Park SJ, Choi HR, et al. Incidence of primary liver cancer in subjects with chronic hepatitis B in Korean National Liver Cancer Screening Program. J Liver Cancer. 2017; 17:136–143.
12. Suh M, Choi KS, Park B, Lee YY, Jun JK, Lee DH, et al. Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat. 2016; 48:1–10.
13. Choi MH, Jung SE, Choi JI, Jeong WK, Kim HC, Kim Y, et al. Quality management of ultrasound surveillance for hepatocellular carcinoma under the Korean National Cancer Screening Program. J Ultrasound Med. 2018; 37:245–254.
14. Kim DY, Kim HJ, Jeong SE, Kim SG, Kim HJ, Sinn DH, et al. The Korean guideline for hepatocellular carcinoma surveillance. J Korean Med Assoc. 2015; 58:385–397.
15. Na SK, Song BC. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C. Clin Mol Hepatol. 2019; 25:234–244.
16. Zhang X, Wong GL, Wong VW. Application of transient elastography in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2019; Nov. 8. . doi: 10.3350/cmh.2019.0001n. [Epub ahead of print].